Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 346-352

  Gao, Zhenqiang ^a   Gao, Zhiping ^a   Fields, Jeremy Z ^a   Boman, Bruce M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA 2 MICROGLOBULIN; CARCINOEMBRYONIC ANTIGEN; COLCHICINE; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; RHODAMINE 123; RIBOZYME; VINBLASTINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033014753     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990730)82:3<346::aid-ijc7>3.0.co;2-%23     Document Type: Article

References (26)

1. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res., 47, 943-946 (1987).
2. CLIFFORD, S.C., NEAL, D.E. and LUNEC, J., High level expression of the multidrug resistance (MDR1) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens? Carcinogenesis, 17, 601-604 (1996).
3. CONNORS, T.A., DUNCAN, R. and KNOX, R.J., The chemotherapy of colon cancer. Europ. J. Cancer, 31A, 1373-1378 (1995).
4. GAO, Z.Q., GAO, Z.P., FIELDS, J.Z. and BOMAN, B.M., Co-transfection of MDR1 and MRP antisense RNAs to reverse the drug resistance in multidrug-resistant human lung cancer cells. Anticancer Res., 17, 3073-3076 (1998).
5. GAO, Z.Q., GAO, Z.P., LIU, X.F., ZHANG, T. and SUN, R.H., Increasing drug resistance in human lung cancer cells by mutant-type p53 gene mediated by retrovirus. Sci. China, 1, 101-106 (1997a).
6. GAO, Z.Q., GAO, Z.P., LIU, X.F., ZHANG, T. and SUN, R.H., Chemotherapy of multidrug resistant human lung cancer with adding an MDR1 ribozyme retrovirus in an orthotopic model. Chin. Sci. Bull., 3, 231-234 (1997b).
7. GAO, Z.Q., GAO, Z.P., ZHANG, T., LIU, X.F. and SUN, R.H., Reversal of drug resistance in multidrug-resistant human lung cancer cells by retrovirus-mediated MDR1 antisense RNA. Chin. Sci. Bull., 24, 1996-2001 (1996).
8. GAO, Z.Q., GAO, Z.P., ZHANG, T., LIU, X.F. and SUN, R.H., Reversal of drug sensitivity in multidrug-resistant lung cancer cells by an MDR1 ribozyme. Chin. Sci. Bull., 1, 64-68 (1997c).
9. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
10. HOLM, P.S., DIETEL, M. and KRUPP, G., Similar cleavage efficiencies of an oligoribonucleotide substrate and an mdr1 mRNA segment by a hammer-head ribozyme. Gene, 167, 221-225 (1995).
11. JOTHY, S., YUAN, S.Y. and SHIROTA, K., Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model. Amer. J. Pathol., 143, 250-257 (1993).
12. KIEHNTOPF, M., BRACH, M.A., LICHT, T., PETSCHAUER, S., KARAWAJEW, L., KIRSCHNING, C. and HERRMANN, F., Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J., 13, 4645-4652 (1994).
13. KOBAYASHI, H., DORAI, T., HOLLAND, J. and OHNUMA, T., Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Cancer Res., 54, 1271-1275 (1994).
14. LI, X., SMYTH, A.P., BARRETT, D.J., IVY, S.P. and VON HOFE, E., Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 induction. Leukemia, 11, 950-957 (1997).
15. LUM, B.L. and GOSLAND, M.P., MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol. Oncol. Clin. North Amer., 9, 319-336 (1995).
16. MILLER, N. and WHELAN, J., Progress in transcriptionally targeted regulatable vectors for genetic therapy. Hum. Gene Ther., 8, 803-815 (1997).
17. O'BRIEN, M.J., ZAMCHECK, N., BURKE, B., KIRKHAM, S.E., SARAVIS, C.A. and GOTTLIEB, L.S., Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value. Amer. J. clin. Pathol., 75, 283-290 (1981).
18. OSAKI, T., TANIO, Y., TACHIBANA, I., HOSOE, S., KUMAGAI, T., KAWASE, I., OIKAWA, S. and KISHIMOTO, T., Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res., 54, 5258-5261 (1994).
19. PETRIZ, J. and GARCIA-LOPEZ, J., Flow cytometric analysis of P-glycoprotein function using rhodamine 123. Leukemia, 11, 1124-1130 (1997).
20. SCANLON, K.J., ISHIDA, H. and KASHANI-SABET, M., Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc. nat. Acad. Sci. (Wash.), 91, 11123-11127 (1994).
21. SCHREWE, H., THOMPSON, J., BONA, M., HEFTA, L.J., MARUYA, A., HASSAUER, M., SHIVELY, J.E., VON KLEIST, S. and ZIMMERMANN, W., Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol. cell. Biol., 10, 2738-2748 (1990).
22. SINICROPE, F.A., HART, J., BRASITUS, T.A., MICHELASSI, F., LEE, J.J. and SAFA, A.R., Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy and disease relapse. Cancer, 74, 2908-2917 (1994).
23. SYMONS, R., Self-cleavage of RNA in the replication of small pathogens of plants and animals. Trends Biochem. Sci., 14, 445-450 (1989).
24. TOLCHER, A.W., COWAN, K.H. and SOLOMON, D., A phase I study of palitaxel with R-verapamil in melastatic breast cancer. Proc. Amer. Soc. clin. Oncol., 13, 139-144 (1994).
25. VON KLEIST, S., HESSE, Y. and KANANEEH, H., Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. Anticancer Res., 16, 2325-2332 (1996).
26. WIECHEN, K., ZIMMER, C. and DIETEL, M., Selection of a high activity c-erbB-1 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein. Cancer Gene Ther., 5, 45-51 (1998).